drugset / Trial / NCT06590870

Intranasal Fentanyl in Preterm Infants Undergoing Peripherally Inserted Central Catheter Placement

NCT06590870

Phase 3 Completed 8 enrolled Mount Sinai Hospital, Canada
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this feasibility clinical trial is to explore the role of intranasal fentanyl for pain associated with PICC placement in preterm infants. The primary goals are identifying whether enough infants join the study and complete the study procedures.

Timeline

Start
2024-08-09
Primary completion
2025-02-09
Completion
2025-02-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Fentanyl Other / unclassified 1.5 ug/kg Intranasal

Indications

No indication recorded.